Lewiston, MN, United States of America

Adam Hume


Average Co-Inventor Count = 4.4

ph-index = 1


Location History:

  • Lewiston, ME (US) (2003)
  • Lewiston, MN (US) (2004)

Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Adam Hume: Innovator in Molecular Biology

Introduction

Adam Hume is a notable inventor based in Lewiston, MN (US). He has made significant contributions to the field of molecular biology, particularly in the area of restriction endonucleases and methylases. With a total of 2 patents to his name, Hume's work has advanced our understanding of genetic engineering.

Latest Patents

Hume's latest patents include a "Method of cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease." This invention relates to recombinant DNA that encodes the BsmBI restriction endonuclease and BsmBI methyltransferase, as well as methods for their expression and purification. Another significant patent is the "Method for cloning and expression of BsaWI restriction endonuclease and BsaWI methylase in E. coli." This invention also focuses on recombinant DNA encoding the BsaWI restriction endonuclease and methylase, along with their expression in host cells.

Career Highlights

Adam Hume is currently associated with New England Biolabs, Inc., where he continues to innovate in the field of molecular biology. His work has been instrumental in developing techniques that enhance the efficiency of genetic manipulation.

Collaborations

Hume has collaborated with notable colleagues such as Shuang-Yong Xu and Jing Zhou. These partnerships have contributed to the advancement of research in the field.

Conclusion

Adam Hume's contributions to molecular biology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the scientific community and advance genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…